CIK 0001835022
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Coya Therapeutics, Inc.
Sign in to watch- Ticker
- COYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-739-3939
- Business address
- 12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, TX, 77024
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 1,800 shares at $7.19 ($12,934)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $7.36 ($36,797)
- 4 Open-market buy Chief Medical Officer bought 2,710 shares at $7.37 ($19,973)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $7.34 ($36,689)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000 shares at $3.62 ($3,620)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 4 · 68 filings